An international team of researchers has shown that it may be possible to improve the effectiveness of the seasonal flu vaccine by 'pre-empting' the evolution of the influenza virus.
Together with a team at the Erasmus Medical Center in Rotterdam, LMU researchers have developed a candidate vaccine directed against the avian flu virus H5N1 and have now carried out the first tests in humans.
Ebola virus has captured the attention of the world since the outbreak in West Africa began months ago, so far claiming nearly 5,000 lives.
After weeks of Ebola panic, false alarms and quibbles over quarantine in the United States, health authorities are bracing for a new battle: flu season.
Amidst fears about the Ebola virus, the current flu season is gaining steam. And many Americans, while completely safe from Ebola, are in danger of becoming seriously ill with a widespread, highly infectious and potentially ...